BioNTech SE (BNTX) Revenue Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -16.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29,853.03% |
| Sep 30, 2025 | 29.89% |
| Jun 30, 2025 | 735.78% |
| Mar 31, 2025 | 144.17% |
| Dec 31, 2024 | -99.78% |
| Sep 30, 2024 | 40.27% |
| Jun 30, 2024 | -80.66% |
| Mar 31, 2024 | -99.27% |
| Dec 31, 2023 | -63.54% |
| Sep 30, 2023 | -72.07% |
| Jun 30, 2023 | -94.65% |
| Mar 31, 2023 | -80.84% |
| Dec 31, 2022 | -31.03% |
| Sep 30, 2022 | -51.39% |
| Jun 30, 2022 | -46.65% |
| Mar 31, 2022 | 189.55% |
| Dec 31, 2021 | -100.00% |
| Sep 30, 2021 | 9,004.77% |
| Jun 30, 2021 | 13,797.80% |
| Mar 31, 2021 | 7,980.20% |
| Sep 30, 2020 | 147.22% |
| Jun 30, 2020 | 58.77% |
| Mar 31, 2020 | 2.87% |
| Sep 30, 2019 | 34.43% |